Oxford Biodynamics

OBD: 125.00 -8.00 (-6.02%) delayed: 12 Nov 2019, 17:30

Trade now

Oxford Biodynamics Fundamentals

Share Price Information

Name Oxford Biodynamics
Epic OBD
Sector Biotechnology
ISIN GB00BD5H8572
Activites Oxford BioDynamics plc is a biotechnology company focused on the discovery and development of epigenetic biomarkers for use within the pharmaceutical and biotechnology industry. The Company's award-winning, proprietary technology platform, EpiSwitch, aims to accelerate the drug discovery and development process, improve the success rate of therapeutic product development and take advantage of the increasing importance of personalised medicine. In particular, EpiSwitch can reduce time to market, failure rates and the costs at every stage of drug discovery. Additionally, the technology provides significant insights into disease mechanisms for drug discovery and product re-positioning programmes, and enables the personalisation of therapeutics for patients in the context of challenging pricing environments where improved clinical outcomes are critical.
Index n/a

Key numbers

Latest Share price (p) 125.00 Net gearing (%) -83.02
Market capitalisation (£m) 123.10 Gross gearing (%) 4.26
Shares in issue (m) 92.56 Debt ratio 0.35
P/E ratio -60.46 Debt-to-equity ratio 0.08
Total dividends per share (p) 0.00 Assets / equity ratio 1.04
Dividend yield (%) 0.00 Price to book value 6.14
Dividend cover 0.00 ROCE (%) -12.03
Earning per share (p) -2.20 EPS growth (%) 51.11
52-week high / low (p) 216.00 / 80.50 DPS growth (%) n/a

Results at a glance

Date Type Turnover (£m) Profit (£m) Basic EPS Currency
30 Sep 2018 Full Year 1 -2 -2.20 GBP
30 Sep 2017 Full Year 1 -4 -4.50 GBP
30 Sep 2016 Full Year 1 -2 -2.10 GBP

Dividend history

Period Ex-date Pay-date Net dividend Currency Total for year

Contact details

Company name Oxford BioDynamics
Address 26 Beaumont Street, Oxford OX1 2NP.
Telephone +44 (0)1865 518 910
Website http://www.oxfordbiodynamics.com/

Advisors

Company's broker Stifel Nicolaus Europe Limited
Company's joint broker n/a
NOMAD Stifel Nicolaus Europe Limited
Registrar Link Asset Services
Auditors KPMG Audit
Solicitors Mayer Brown LLP

Directors

Appointed Director Position
25 Apr 2007 Christian Gurth Hoyer-Millar Chief Executive Officer
15 Sep 2017 Paul Leslie Stockdale Chief Financial Officer
08 Jun 2007 Dr Alexandre Akoulitchev Chief Scientific Officer
04 Oct 2016 Stephen Charles Diggle Non-Executive Chairman
05 Apr 2019 Dr David Mark Anthony Holbrook Non-Executive Director
05 Apr 2019 Dr Peter Pack Non-Executive Director

Company financials

Assets (£m) 2018 2017 2016
Reporting date 30 Sep 2018 30 Sep 2017 30 Sep 2016
Tangible assets 1 1 1
Intangible asssets and goodwill 0 0 0
Investments and other non-current assets 0 0 0
Total non-current assets 1 1 1
Inventory / work in progress 0 0 0
Trade and other receivables 1 1 1
Cash and equivalents 18 11 7
Other current assets and asset held for resale 0 0 0
Total of all assets 21 13 9
Liabilities (£m) 2018 2017 2016
Short term liabilities 1 1 1
Long term liabilities 0 0 0
Other liabilites / pension etc 0 0 0
Total of all liabilities 1 1 1
Net assets (£m) 2018 2017 2016
Net assets 20 12 8
Equity (£m) 2018 2017 2016
Share capital 1 1 1
Minority interests 0 0 0
Retained earnings -0 0 4
Share premium account 17 7 0
Other equity 3 4 3
Total equity 20 12 8
Cash Flow (£m) 2018 2017 2016
Cash from operating activities -2 -2 -1
Cashflow before financing -3 -2 -2
Increase / decrease in Cash 7 4 -2
Income (£m) 2018 2017 2016
Turnover 1 1 1
Cost of sales 0 0 0
Gross profit 0 0 0
Operating profit -3 -4 -2
Pre-tax profit -2 -4 -2
Profit / loss for the year -2 -4 -2